Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register

Validation of biomarkers survey infographic

10 Sep 2018
Biomarkers MS (LC–MS/MS, HRMS, IMS)

As part of our Spotlight on the validation of biomarkers, we conducted a survey and compared the results to previous data. Find out more about the key trends, challenges and future potential for biomarker R&D in this informative infographic.

DON’T MISS the panel discussion, where our experts will be discussing the results of the survey and more about biomarker R&D.

LB_Q3-spotlight-PANEL

In the zone validation of biomarkers_v3-page-001 (1)

Top content

  • A pivotal peril of profoundly pernickety peptides
  • An author’s perspective: Shuanglin Qin on advancing oligonucleotide-based PROTACs for undruggable therapeutic targets
  • Mastering bioanalytical project management

Related tags

infographic Spotlight Survey
Previous article Next article

Related articles

2 OCT 2023 MS (LC–MS/MS, HRMS, IMS)
Spotlight survey: considerations around validation of methods for hybrid LC-MS/MS assays using non-primary matrices
7 JAN 2016 DRUG DEVELOPMENT
Christopher Beaver details his thoughts on the recent biomarker (and biosensors) Spotlight survey and the consensus of APPS Workshop on Crystal City VI: BMV for Biomarkers
14 JAN 2019 CHROMATOGRAPHY
Spotlight survey on proteomics
3 SEP 2019 GENERAL INTEREST
Infographic: trends in LBA
8 OCT 2018 DATA PROCESSING AND INTERPRETATION
Top 5 tips to set-up and run any flow cytometry assay
26 APR 2019 INTERVIEWS
Exosomes in flow cytometry: an interview with Joyce Slusser
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone